SCM
ASND icon

Scopia Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Scopia Capital Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-148,114
Closed -$2.6M – 43
2015
Q2 		$2.6M Buy
148,114
+23,114
+18% +$404K 0.05% 36
2015
Q1 		$2.17M Buy
+125,000
New +$2.27M 0.05% 27

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Scopia Capital Management's ASND Position: Q3 2015 in Review

Scopia Capital Management sold out of Ascendis Pharma A/S (ASND) in Q3 2015, closing a stake of 148,114 shares — an estimated $2.6M sold.

Scopia Capital Management first reported a position in ASND in Q1 2015 and held it in 2 quarters. The position peaked at $2.6M in Q2 2015. 26 funds tracked by Wall St. Rank hold ASND as of Q3 2015.

  • Scopia Capital Management reported no remaining Ascendis Pharma A/S position as of Q3 2015 after selling out during the quarter.
  • Scopia Capital Management sold 148,114 Ascendis Pharma A/S shares in Q3 2015, an estimated $2.6M.
  • Scopia Capital Management first reported a position in Ascendis Pharma A/S in Q1 2015 and held it in 2 quarters.
  • Scopia Capital Management's Ascendis Pharma A/S position peaked at $2.6M in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2015.

Based on Scopia Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.